You just read:

U.S. FDA Approves Alexza's ADASUVE® (loxapine) Inhalation Powder for the Acute Treatment of Agitation Associated with Schizophrenia or Bipolar I Disorder in Adults

News provided by

Alexza Pharmaceuticals, Inc.

Dec 21, 2012, 03:25 ET